Cubist Systematic Strategies’s Verona Pharma VRNA Stock Holding History

Cubist Systematic Strategies’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.22M	Sell	48,910 -48,737	-50%	-$5.09M	0.02%	940
2025 Q2	$9.24M	Sell	97,647 -61,443	-39%	-$4.55M	0.04%	653
2025 Q1	$10.1M	Buy	+159,090	New	+$9.52M	0.06%	474
2024 Q2	–	Sell	-13,682	Closed	-$220K	–	4096
2024 Q1	$220K	Buy	+13,682	New	+$237K	﹤0.01%	3035
2023 Q1	–	Sell	-19,300	Closed	-$504K	–	4465
2022 Q4	$504K	Sell	19,300 -23,577	-55%	-$314K	﹤0.01%	3011
2022 Q3	$438K	Buy	+42,877	New	+$361K	﹤0.01%	3267

Other funds holding VRNA

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's VRNA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Verona Pharma (VRNA) stake by 50% in Q3 2025, selling an estimated $5.09M and leaving 48,910 shares worth $5.22M. The position accounts for 0.02% of the portfolio, ranked #940.

Cubist Systematic Strategies first reported a position in VRNA in Q3 2022 and has held it in 6 quarters since. The position peaked at $10.1M in Q1 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

Cubist Systematic Strategies held 48,910 shares of Verona Pharma worth $5.22M as of Q3 2025.
Cubist Systematic Strategies sold 48,737 Verona Pharma shares in Q3 2025, an estimated $5.09M.
Verona Pharma made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #940 holding.
Cubist Systematic Strategies first reported a position in Verona Pharma in Q3 2022 and has held it in 6 quarters since.
Cubist Systematic Strategies's Verona Pharma position peaked at $10.1M in Q1 2025.
243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.